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A method is more important than a discovery, since the right
method will lead to new and even more important discoveries.
-Lev D. Landau, Nobel Prize laureate
Welcome to Molecular Cytogenetics. We are proud to intro-
duce you to a new home for biomedical research focused
on all aspects of chromosome biology and applications of
molecular cytogenetic techniques in all areas of biomedi-
cine. Molecular Cytogenetics [1] represents the first open
access source for research concerning molecular cytoge-
netic techniques. Molecular Cytogenetics will be a valuable
resource for researchers all over the world, both those who
are already experts and those entering the field.
Molecular cytogenetics comprises a set of the techniques
operating with either the entire genome or with specific
DNA sequences to study genome structure and functions
at the chromosomal level. Molecular cytogenetics can also
be defined as a specific focus of biomedical sciences tar-
geted at studying chromosomes at molecular and single-
cell resolutions and at all stages of the cell cycle. Further-
more, the area of molecular cytogenetic technique appli-
cations has come to encompass almost everything from
applied research in clinical and cancer genetics to basic
studies in cellular and structural biology, genomics, genet-
ics, and neurosciences. Thus, a journal focused on molec-
ular cytogenetics is not limited to technical issues but will
also address advances in current biomedical research.
Molecular Cytogenetics will provide multilateral coverage of
numerous applied and basic aspects of current biomedi-
cine.
Taking into account the growing amount of biomedical
journals available, one can argue whether we need
another one. However, any scientist working on theoreti-
cal and practical aspects of chromosome biology would
undoubtedly agree that there are few journals covering
this area of biology, and that there are no journals provid-
ing immediate open access. We performed an informal
analysis (Figure 1) that shows the consistent interest of
researchers to publish their original molecular cytogenetic
data in peer-reviewed journals. However, to read the larg-
est proportion of articles (over 70%) related to molecular
cytogenetics, one has to have a subscription. Therefore,
numerous scientists all over the world, especially those in
the developing countries, miss the opportunity to keep
abreast with the latest advances in molecular cytogenetics.
A number of journals indirectly related to molecular
cytogenetics make articles free toaccess after a set period of
time, but still non-subscribers, regardless of their intellec-
tual potential, have to operate with backward data, there-
fore having fewer opportunities to take a well deserved
place in competition with those who have immediate
access. Moreover, a recent survey describes open access
articles as benefiting science by accelerating dissemina-
tion and uptake of research findings [2]. Since there are no
open access journals in the fields of chromosome biology
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gap in current biomedical publishing.
Molecular cytogenetics is a rapidly evolving field of bio-
medicine. Throughout the last decade, significant break-
throughs in molecular cytogenetics have been made. This
can be attributed in part to the establishment of new com-
posite molecular cytogenetic technologies that have sig-
nificantly enhanced diagnosis in medical and cancer
genetics, for example the conception of molecular karyo-
typing using microarray (array-CGH) and more sophisti-
cated digital karyotyping for identification of subtle
genomic imbalances and copy number changes at molec-
ular resolutions. New technologies are expected to follow
at this rapid pace. Molecular cytogenetic techniques pos-
sess the potential not only to become more efficient
through further enhancements and modifications, but
also to lead to new and important discoveries in biomed-
icine. In this context, the lack of a journal exclusively ded-
icated to molecular cytogenetics can be considered an
omission. Therefore, Molecular Cytogenetics fills another
gap in current biomedical publishing.
Molecular Cytogenetics aims to become a significant inter-
national participant in the fields of genetics and cell biol-
ogy. The purpose of the journal is, therefore, to publish
timely and high-quality articles concerning chromosome
biology and the application of molecular cytogenetic tech-
niques in all areas of biomedicine. To achieve this, the
Editorial Board of Molecular Cytogenetics gathers well-
known experts from all over the world [3]. To make a deci-
sion whether a manuscript fits the format of publishing in
Molecular Cytogenetics, the Editors-in-Chief or correspond-
ing specialists from the Editorial Board will immediately
screen a submission and appropriate manuscripts will be
sent for peer review to two independent reviewers. Based
on their reports and scoring, a final decision will be made
regarding acceptance of the manuscripts. Editors-in-Chief
reserve the right to make final decisions concerning each
manuscript submitted to the journal. At first sight our peer
review system does not significantly differ from that pro-
posed by other journals. However, we encourage our Edi-
torial Board members as well as reviewers to be motivated
critical advisers for improving a manuscript rather than
rigorous censors for biomedical publishing, which is
unfortunately a common experience for anyone who has
ever tried to publish his or her original research results.
Molecular Cytogenetics is published by the open access pub-
lisher, BioMed Central [4]. BioMed Central ensures all
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"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
articles published in the journal are listed in PubMed and
archived in PubMed Central, and other national archives.
When submitting an article authors will be required to
complete a declaration of competing interests. In addi-
tion, for all articles accepted for publication an article-
processing charge will be levied, to cover the costs
incurred by open access publication. We believe that
authors' ability to publish research should be governed
only by the quality of the work and not financial limita-
tions. Therefore, article-processing charges (APCs) will be
comparable to and no more cost-prohibitive than the
color figure publication fees assessed by most scientific
journals. In addition, over 300 institutes have committed
to a BioMed Central institutional membership[5],
whereby they cover the full or partial cost of the APC, and
a number of funding bodies actively support open access
and explicitly allow direct use of their grants to cover APCs
[6]. Waivers can be requested by authors who have a gen-
uine inability to pay the charge. The most common reason
for publication rejection being the lack of space in a jour-
nal, another advantage of Molecular Cytogenetics is that
there are no limitations regarding space or color figures.
Considering all the advantages Molecular Cytogenetics pos-
sesses, we believe the journal to be of great benefit to the
field of biomedicine. We invite you to work together with
us to create this new and high-visibility open-access forum
for the biomedical sciences.
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